1Paul N. Span,Vivianne C.G. Tjan-Heijnen,Peggy Manders,Doorlene Tienoven,Jeffrey Lehr,Fred C.G.J. Sweep. High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer[J] 2006,Breast Cancer Research and Treatment(2):223～230
2Chiyomi Egawa,Kazuyoshi Motomura,Yasuo Miyoshi,Yuuki Takamura,Tetsuya Taguchi,Yasuhiro Tamaki,Hideo Inaji,Hiroki Koyama,Shinzaburo Noguchi. Increased Expression of BRCA1 mRNA Predicts Favorable Response to Anthracycline-Containing Chemotherapy in Breast Cancers[J] 2003,Breast Cancer Research and Treatment(1):45～50
3Qi-Feng Yang,Takeo Sakurai,Goro Yoshimura,Liang Shan,Takaomi Suzuma,Takeshi Tamaki,Teiji Umemura,Yozo Kokawa,Yasushi Nakamura,Misa Nakamura,Weihua Tang,Hirotoshi Utsunomiya,Ichiro Mori,Kennichi Kakudo. Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma[J] 2000,Breast Cancer Research and Treatment(3):211～216
